GC MS and LC MS Standards
eMolecules Pharmablock / 5-methoxy-1H-indazole / 25mg / 551065643 / PB02632 / 0.000 / 94444-96-9 / MFCD07781657 / 148.165 / C8H8N2O
Pharmablock / 5-methoxy-1H-indazole / 25mg / 551065643 / PB02632 / 0.000 / 94444-96-9 / MFCD07781657 / 148.165 / C8H8N2O
Cayman Chemical 12 13EpOMEd4 GC MS Standards
An internal standard for the quantification of 12(13)-EpOME by GC- or LC-MS
Cayman Chemical Lipoxin A4d5 GC MS Standards
An internal standard for the quantification of Lipoxin A4 by GC- and LC-MS
Cambridge Isotope Laboratories Bile acid standard mix 2 (20X) conjugated (unlabeled) 1 vial
Bile acid standard mix 2 (20X) conjugated (unlabeled) 1 vial
eMolecules Pharmablock / 2-methoxy-5-(4455-tetramethyl-132-dioxaborolan-2-yl)pyrimidine / 25mg / 721772788 / PBS63821 / 0.000 / 1052686-60-8 / MFCD13182190 / 236.080 / C11H17BN2O3
Pharmablock / 2-methoxy-5-(4455-tetramethyl-132-dioxaborolan-2-yl)pyrimidine / 25mg / 721772788 / PBS63821 / 0.000 / 1052686-60-8 / MFCD13182190 / 236.080 / C11H17BN2O3
Medchemexpress LLC Substance P (Neurokinin P) | 33507-63-0 | 99.52% | 1347.63 | 10 MG
Substance P (Neurokinin P) is a central nervous system (CNS)-penetrant neuropeptide. It acts as both a neurotransmitter and neuromodulator within the CNS, primarily targeting the endogenous neurokinin 1 receptor (NK1-receptor, NK1R).
- Functions as a neurotransmitter and neuromodulator
- Endogenous receptor is neurokinin 1 receptor (NK1R)
- Appearance is solid, white to off-white
- Soluble in water
- Suitable for in vivo applications with various solvents
![eMolecules Pharmablock / 4-(1H-pyrazol-4-yl)-7H-pyrrolo[23-d]pyrimidine / 25mg / 551225505 / PB93040 / 0.000 / 952518-97-7 / MFCD20683197 / 185.190 / C9H7N5](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502440203.PNG-250.jpg)
eMolecules Pharmablock / 4-(1H-pyrazol-4-yl)-7H-pyrrolo[23-d]pyrimidine / 25mg / 551225505 / PB93040 / 0.000 / 952518-97-7 / MFCD20683197 / 185.190 / C9H7N5
Pharmablock / 4-(1H-pyrazol-4-yl)-7H-pyrrolo[23-d]pyrimidine / 25mg / 551225505 / PB93040 / 0.000 / 952518-97-7 / MFCD20683197 / 185.190 / C9H7N5
![eMolecules Pharmablock / 1-benzyl-1-azaspiro[4.4]nonan-9-one / 25mg / 551229608 / PB96519 / 0.000 / 2221965-34-8 / [null] / 229.323 / C15H19NO](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502440177.PNG-250.jpg)
eMolecules Pharmablock / 1-benzyl-1-azaspiro[4.4]nonan-9-one / 25mg / 551229608 / PB96519 / 0.000 / 2221965-34-8 / [null] / 229.323 / C15H19NO
Pharmablock / 1-benzyl-1-azaspiro[4.4]nonan-9-one / 25mg / 551229608 / PB96519 / 0.000 / 2221965-34-8 / [null] / 229.323 / C15H19NO
Cayman Chemical tetranorPGDMd6 GC MS Standards
An internal standard for the quantification of tetranor-PGDM by GC- or LC-MS
Cayman Chemical 4oxo2Nonenald3 GC MS Standards
An internal standard for the quantification of 4-ONE by GC- or LC-MS
Cayman Chemical 8 9DiHETd11 GC MS Standards
An internal standard for the quantification of 8(9)-DiHET by GC- or LC-MS
Waters Corp Vion IMS QTof Performance Maintenance Kit with Chemical Kit
Vion IMS QTof Performance Maintenance Kit with Chemical Kit
Cayman Chemical 5 6EETd11 GC MS Standards
An internal standard for the quantification of 5(6)-EET by GC- or LC-MS
Cayman Chemical 8 9DiHETd11 GC MS Standards
An internal standard for the quantification of 8(9)-DiHET by GC- or LC-MS